Now He's Collaborating on a Tool to Help Them The art portfolio platform Cara, designed for creators who don't want their work used to train AI, has been under assault by trolls seizing and publishing its data. Since early 2023, photographer Jingna Zhang and a small crew of volunteers have worked tirelessly to maintain an image-sharing social media and portfolio app called Cara . So far, it has attracted about 1.5 million artists. What drew them to the platform? A shared opposition to the unauthorized use of their work to train AI models and a desire to publicize their art while avoiding exploitation by Big Tech.

AI companies like Anthropic and OpenAI regularly publish reports on how people are using products like Claude and ChatGPT, but they only release the data they want us to see, AI researchers say. "There is no independent source to corroborate it," says Anka Reuel, a computer science PhD candidate at the Stanford Trustworthy AI Research (STAIR) Lab. Reuel is co-lead of a new research project, called the AI Observatory, that aims to fill the gap. It's a public platform that aggregated and analyzed real AI conversations with popular models like Claude and Gemini that were collected with users' consent through seven existing datasets. The intent is to provide independent sources of information that can help researchers and policymakers assess how people are using generative AI. Highly consequential decisions about AI's benefits and risks are currently being made on the basis of very limited data, says Reuel.

AI agents that can model the human process of research will accelerate discoveries in science. Every few decades, someone announces that science has reached its end. In 1903, the revered physicist Albert Michelson wrote that the "facts of physical science have all been discovered." In the 1980s, Stephen Hawking predicted that theoretical physics might be finished by the end of the century. With the explosive arrival of artificial intelligence, the feeling is in the air again--this time accompanied by a Nobel Prize. In 2024, Demis Hassabis and John Jumper of Google DeepMind were awarded part of the Nobel in chemistry for their neural network AlphaFold, which predicts the three-dimensional structures of proteins by learning from thousands of experimentally measured shapes.

As generative AI captures public attention, a different kind of AI is reshaping drug discovery. Machine learning models are helping to compress decade-long timelines and cracking problems that were previously unsolvable. Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered proteins rather than synthetic chemistry (which are often used to treat conditions across most major acute and chronic diseases), the complexity is even greater.

Conditional inference trees (CIT) and conditional inference forests (CIF) reduce split-selection bias by testing features before choosing split thresholds, but repeated permutation tests and threshold searches can make these methods computationally expensive. We study CIT and CIF as top-$k$ feature-ranking methods for downstream prediction using real-data benchmarks, runtime ablations, and synthetic feature-recovery experiments. At a fixed node, if the features and permutation budget do not depend on the node responses, Bonferroni-corrected $+1$ Monte Carlo permutation $p$-values control nodewise rejection under the complete permutation null. CIF ranks 4th among 17 classification methods on 22 datasets and 3rd among 18 regression methods on 8 datasets. With Bonferroni correction held fixed, the CIF runtime ablations indicate that adaptive stopping and the number of thresholds searched have the largest measured effect on runtime: turning off adaptive stopping and using exact threshold search increase fitting time by 4.0--8.4$\times$ and 1.9--10.8$\times$, respectively, while downstream score changes are at most 0.011. Sparse high-$p$ simulations indicate that forest feature sampling can leave informative features out of many split decisions. Overall, the results support CIF as a top-$k$ feature-ranking method in the evaluated downstream prediction benchmarks.

We propose a scaling law that takes into account model size and training data while explicitly splitting the latter into training steps and batch size (called three-term law). Fitting the proposed law on a large set of training runs, we find that it correctly recovers the scaling of the optimal batch size. Moreover, because it makes use of training runs with suboptimal batch size, our proposed law can be robustly fit with a significantly smaller amount of training runs. We further show that the three-term law can be used to derive scaling laws for suboptimal batch sizes, and that it matches previous empirical findings related to the critical batch size.

Variational Autoencoders (VAEs) commonly assume a standard isotropic Gaussian prior over the latent space, an assumption that often fails to capture the true distribution of latent representations for complex datasets. This mismatch can limit reconstruction accuracy, reduce sample quality, and constrain the expressive power of the learned latent space. We propose the eXact-Prior Variational Autoencoder (X-VAE), a framework that replaces the conventional standard normal prior with a Gaussian prior derived from the latent representations of a pretrained autoencoder (AE). Specifically, the empirical mean and standard deviation of the AE latent codes are used to parameterize a data-adaptive prior that more closely reflects the underlying structure of the training data. During generation, X-VAE introduces a latent scaling factor that enables explicit control over the variance of the sampled latent vectors, providing a simple mechanism for balancing sample diversity and fidelity. This flexibility makes the proposed approach particularly well suited for applications such as industrial and engineering design, where generated solutions must satisfy strict structural or functional constraints while still permitting meaningful design exploration. We present the mathematical formulation of well-suited X-VAE, derive the corresponding KL divergence objective for the proposed prior, and evaluate the method on standard benchmark datasets. Experimental results demonstrate that X-VAE preserves reconstruction quality while producing latent representations that better align with the empirical data distribution, leading to improved controllability and more realistic generated samples.

Recent work has established a fundamental trilemma between Byzantine robustness, local differential privacy (LDP), and optimization error in distributed learning. We show that this trilemma does not universally extend to generalization error, but instead depends critically on the privacy regime. Specifically, in the high-noise regime (strong privacy), we prove that increasing privacy reduces the generalization error, i.e., there is no tension between robustness and privacy. In the low-noise regime (weaker privacy), however, the tension between robustness and privacy reappears and increasing privacy indeed degrades generalization. Our theory explains this surprising non-monotonic behavior of the generalization error via matching lower and upper bounds on the algorithmic stability of Byzantine-robust distributed learning under LDP constraints. We corroborate and further analyze these theoretical findings with empirical evaluations.

Aqueous solubility is a key property in early-stage drug discovery, but most predictive models merge physicochemical descriptors and molecular graph information into a single representation, obscuring whether a prediction is driven by global chemistry, molecular structure, or both. We present an additive deep-learning framework that keeps these two sources of information separate throughout training: physicochemical descriptors are encoded by a multilayer perceptron (the chemical branch) and molecular graph topology by a graph neural network (the structural branch), with the two outputs combined only at the prediction stage through an additive model with an optional multiplicative interaction. This design provides a direct decomposition of chemical and structural components that can be examined separately after training. Furthermore, pretraining on the larger AqSolDB dataset and fine-tuning on the smaller BigSolDB2 dataset substantially improve accuracy and reduce run-to-run variations, indicating generalizability of the learned features from the data-rich settings. We further interpret the fitted model using best linear projections of the branch outputs, molecule-level embedding summaries across solubility classes, and atom-level GNNExplainer masks aggregated over functional groups. These analyses show that the chemical branch aligns with familiar physicochemical descriptors, while the structural branch captures graph-topological and functional-group patterns associated with solubility. Across both datasets, the framework attains competitive predictive performance while making the distinct roles of chemical and structural information more transparent.

Protein engineering is a field primed for artificial intelligence research. Each protein is made up of amino acids; to optimize a protein function, researchers modify proteins by switching out one of 20 different amino acids for another. For a protein that is just 50 amino acids in length, this leads to approximately 1.13 10 potential combinations to test. This number of potential combinations, impossible to test in the lab, makes protein engineering an ideal challenge for AI. Modeling which of these combinations will give the best results is a perfect problem for the technology's massive computing power.